From USFDA
Aurobindo Pharma has received final approval from the US Food and Drug Administration to manufacture and market Meropenem Injection 500 mg/vial and 1 g/vial. Aurobindo's Meropenem injection is a generic equivalent of AstraZeneca Pharmaceuticals' Merrem injection. The product will be launched in April 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
